Recombinant influenza vaccine

0 marketed 2 in Phase 3

This page covers all Recombinant influenza vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Influenza hemagglutinin (HA) antigens.

Targets

Influenza hemagglutinin (HA) antigens

Phase 3 pipeline (2)

GSK Bio's influenza vaccine GSK2186877A · GlaxoSmithKline · Immunology / Infectious Disease
GSK2186877A is a recombinant influenza vaccine designed to stimulate immune responses against influenza virus through a novel antigenic approach.
cTIV · Novavax · Immunology / Infectious Disease
cTIV is a recombinant tetravalent influenza vaccine designed to provide broader and more durable immune protection against multiple influenza virus strains.